Clinical Trials Sponsored by GC Cell Corporation

Total 91 results

Green Cross Corporation

Unknown

Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine

Whooping Cough | Tetanus | Diphtheria

Korea, Republic of
Green Cross Corporation

Unknown

A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults

Influenza, Human
Green Cross Corporation

Completed

An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia

Immune Thrombocytopenia

Korea, Republic of
Green Cross Corporation

Unknown

Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult

Healthy
Green Cross Corporation

Completed

To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC3102C' Administered Intramuscularly in Healthy Adults

Prophylaxis Against Influenza
Green Cross Corporation

Completed

To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children

Bacterial Infections

Korea, Republic of
Green Cross Corporation

Completed

Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)

Influenza

Korea, Republic of
Green Cross Corporation

Completed

A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)

Influenza

Korea, Republic of
Green Cross Corporation

Unknown

The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients

Hunter Syndrome

Korea, Republic of
Green Cross Corporation

Completed

Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.

Prevention of Influenza
Green Cross Corporation

Completed

Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A

Hemophilia A
Green Cross Corporation
Parexel

Completed

A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers

Healthy Volunteers

United States
Green Cross Corporation
Symyoo

Completed

GCPGC in Chemotherapy-induced Neutropenia

Chemotherapy Induced Neutropenia

Korea, Republic of
Green Cross Corporation
Symyoo

Terminated

GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock

Septic Shock | Severe Sepsis

Korea, Republic of
Green Cross Corporation
Symyoo

Completed

To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin

Healthy Volunteer
Green Cross Corporation
Quintiles, Inc.

Completed

A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers

Healthy Male

United States
Green Cross Corporation
Atlantic Research Group

Recruiting

Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency

Primary Immune Deficiency

United States
Green Cross Corporation
Dream CIS, Inc.

Completed

A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients

Hemophilia

Korea, Republic of
Green Cross Corporation
Atlantic Research Group

Completed

Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency

Immunologic Deficiency Syndrome

United States, Canada
Green Cross Corporation
Atlantic Research Group

Unknown

Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A

Hemophilia A

United States
TotipotentRX Cell Therapy Pvt. Ltd.
TotipotentRX Corporation

Unknown

Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients. (AMIRST)

Acute Myocardial Infarction

India
Green Cross Corporation
ICON Clinical Research

Terminated

Safety Study of MG1102 in Patients With Solid Tumors

Solid Tumors

Korea, Republic of
Green Cross Corporation
Atlantic Research Group

Unknown

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

Hemophilia A

United States, Canada, New Zealand, Poland, Russian Federation, Ukraine, United Kingdom
Green Cross Corporation
Parexel; Atlantic Research Group

Completed

Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency

Immunologic Deficiency Syndromes

Canada, United States
Green Cross Corporation
C&R Research, Inc.; CRScube

Unknown

Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis

Gastritis

Korea, Republic of
Beijing 302 Hospital
VCANBIO Cell & Gene Engineering Corporation, Ltd

Recruiting

Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)

Decompensated Cirrhosis

China
Green Cross Corporation
Korean Center for Disease Control and Prevention

Completed

Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers

Influenza

Korea, Republic of
Green Cross Corporation
Korean Center for Disease Control and Prevention

Completed

A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 (GC1109)

Anthrax

Korea, Republic of
Green Cross Corporation
Korean Center for Disease Control and Prevention

Completed

Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers

Influenza

Korea, Republic of
Alliancells-PuRui Biocience Co., Ltd.
Zhongyuan Union Stem Cell Bio-engineering Corporation

Unknown

Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection

Renal Cell Carcinoma | Hepatocellular Carcinoma | Lung Cancer

China
National Taiwan University Hospital
National Taiwan University Tai-Chen Cell Therapy Center, Biomdcare Corporation

Recruiting

Establishing Automatic Method of Counting and Classify Bone Marrow and Peripheral Blood Cells

Hematologic Diseases | Acute Leukemia | Artificial Intelligence

Taiwan
United States Naval Medical Center, San Diego
CEL-SCI Corporation

Terminated

Safety Study of Multikine in the Treatment of Perianal Warts

Condyloma

United States
Hamilton Health Sciences Corporation
AFP Innovation Fund; Stem Cell Network; Ontario Institute for Regenerative Medicine

Not yet recruiting

A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells (Integra®-SC)

Burns

Canada
Renmin Hospital of Wuhan University
VCANBIO Cell & Gene Engineering Corporation, Ltd; Wuhan Optics Valley Zhongyuan...

Recruiting

Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)

Cirrhosis Due to Hepatitis B

China
CEL-SCI Corporation
United States Naval Medical Center, San Diego; Ergomed Clinical Research Inc.

Terminated

Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts (PAW)

Perianal Warts

United States
CEL-SCI Corporation
Teva Branded Pharmaceutical Products R&D, Inc.; Orient Europharma Co., Ltd.

Completed

Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity (IT-MATTERS)

Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Soft Palate

Spain, Taiwan, United States, United Kingdom, Romania, India, Croatia, Belarus, Hungary, Bosnia and Herzegovina, Russian Federation, Austria, Canada, France, Israel, Italy, Malaysia, Poland, Serbia, Sri Lanka, Thailand, Turkey, Ukraine
Beijing 302 Hospital
LanZhou University; Chinese PLA General Hospital; Renmin Hospital of Wuhan University and other collaborators

Recruiting

Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis

Decompensated Cirrhosis

China
Beijing 302 Hospital
Maternal and Child Health Hospital of Hubei Province; Huoshenshan Hospital; VCANBIO... and other collaborators

Completed

Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)

Corona Virus Disease 2019(COVID-19)

China
Beijing 302 Hospital
Fifth Affiliated Hospital, Sun Yat-Sen University; Shenzhen Third People's... and other collaborators

Unknown

Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19

COVID-19

China
Brixsana Private Clinic - Centro di Chirurgia Plastica...
Ludwig Boltzmann Institute for Traumatology - The research center in cooperation... and other collaborators

Completed

Targeted Sensory Reinnervation (TSR) in Hand Amputation

Amputation | Phantom Pain | Targeted Sensory Reinervation

Austria, Italy
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; M.D. Anderson Cancer Center; Dana-Farber Cancer Institute and other collaborators

Active, not recruiting

Molecular Studies and Clinical Correlations in Human Prostatic Disease

Prostate Cancer

United States

Clinical Trials Sponsored by GC Cell Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations